MEL Science raised €12M in a Series B round in Dec 2020. The company is based in Sankt-Peterburg, Russia. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
No investors disclosed for this round.
